Skip to content

H-34 DELTA Revision Cup

An Open Label, Observational, Prospective, Longitudinal Cohort Study to Evaluate Safety, Clinical and Radiographic Outcomes of Total Hip Arthroplasty With DELTA Revision Cup

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT06359301
Enrollment
49
Registered
2024-04-11
Start date
2021-09-14
Completion date
2028-12-01
Last updated
2026-01-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Hip, Osteoarthritis

Keywords

revision

Brief summary

THis study is aimed to provide a clinical and radiographic evaluation of 49 suitable subjects who underwent a total hip arthroplasty with DELTA Revision acetabular cup.

Detailed description

This is an observational study designed to reflect real life clinical practice as closely as possible. Thus, clinicians are free to choose the method to implant and total hip arthroplasty in accordance with the current local Delta Revision acetabular cup Indication for Use and current clinical practice.

Interventions

DEVICEDELTA Revision acetabular cup

Total hip arthroplasty

Sponsors

Limacorporate S.p.a
Lead SponsorINDUSTRY

Study design

Observational model
CASE_ONLY
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* male or female in whom a decision has already been made to perform a total hip arthroplasty with DELTA Revision acetabular cup as per indication for use. The decision to implant DELTA revision acetabular cup must be taken prior to, and independently from the decision to enroll the patient. This decision should be made in accorsance with routine clinical practice at the study site concerned. * Age ≥ 18 years old * All patients mist give written informed consent approved by the study site's Institutinal Review Board (IRB)/Ethical Committee (EC) * Patient is able to comply with the protocol

Exclusion criteria

* Adult patients with any DELTA Revision acetabular cup contraindication for use as reported in the current local instruction for use. * For female patiens, current pregnancy and/or lactation or planning a pregnancy

Design outcomes

Primary

MeasureTime frameDescription
Harris Hip Score (HHS)From preoperative to 2 years after surgeryOverall score from 0 to 100, with 100 being the best outcome

Secondary

MeasureTime frameDescription
ROM measurementFrom preoperative to 2 years after surgeryFunctional changes in ROM measurements from pre-operative (baseline), discharge, 2 months, 6 months, 1 year and 2 years
Oxforn Hip Score (OHS)From preoperative to 2 years after surgeryOverall score from 0 to 48, with 48 being the best outcome
Survival rate2 yearsSurvival rate expressed with Kaplan-Meier estimator at 2 years after surgery
Radiographic implant evaluation and stability assessment of the DELTA Revision acetabular cupFrom preoperative to 2 years after surgeryThe treated hip is analyzed postoperatively based on anteroposterior and lateral x-rays view of the knee to check for radiographic stability and radiographically detectable complications
Incidence, type and severity of all the Adverse Events (AEs), Serious Adverse Events (SAEs), Adverse Device Effects (ADEs), and Serious Adverse Device Effects (SADEs) occurred at each follow-upFrom preoperative to 2 years after surgery

Countries

Poland

Contacts

CONTACTFederica Azzimonti
federica.azzimonti@limacorporate.com+39 377 5450940
PRINCIPAL_INVESTIGATORJerzy Bialecki

Samodzielny Publiczny Szpital Kliniczny im. Prof. Adama Grucy CMKP

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026